The importance of assessing the dose actually administered in pharmacokinetic trials

Clinical Pharmacology and Therapeutics

Volumn 77, Issue 4, 2005, Pages 235-240

  Buclin, Thierry ^a   Perrottet, Nancy ^a   Biollaz, Jerome ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; ERYTHROMYCIN; HYPERICUM EXTRACT; KETAMINE; MIDAZOLAM; MORPHINE 6 GLUCURONIDE;

ACCURACY; ANALYTIC METHOD; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; HUMAN; IMMUNOASSAY; MEDICAL LITERATURE; MEDICAL RESEARCH; NOTE; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD;

AREA UNDER CURVE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, INVESTIGATIONAL; HUMANS; PRACTICE GUIDELINES;

EID: 16344366273     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.11.006     Document Type: Note

References (17)

1. F.S. Chow, L.J. Benincosa, S.B. Sheth, D. Wilson, C.B. Davis, E.A. Minthorn Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans Clin Pharmacol Ther 71 2002 235 245
2. S.M. Eppler, D.L. Combs, T.D. Henry, J.J. Lopez, S.G. Ellis, J.H. Yi A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans Clin Pharmacol Ther 72 2002 20 32
3. Z. Wang, M.A. Hamman, S.M. Huang, L.J. Lesko, S.D. Hall Effect of St John's wort on the pharmacokinetics of fexofenadine Clin Pharmacol Ther 71 2002 414 420
4. C.A. Haller, P. Jacob III, N.L. Benowitz Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use Clin Pharmacol Ther 71 2002 421 432
5. M.F. Paine, D.A. Wagner, K.A. Hoffmaster, P.B. Watkins Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin Clin Pharmacol Ther 72 2002 524 535
6. C.R. Kumana, W.Y. Au, N.S.L. Lee, M. Kou, R.W.M. Mak, C.W. Lam Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies Eur J Clin Pharmacol 58 2002 521 526
7. P.D. Knoester, D.M. Jonker, R.T. Van Der Hoeven, T.A. Vermeij, P.M. Edelbroek, G.J. Brekelmans Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray a study in healthy volunteers Br J Clin Pharmacol 53 2002 501 507
8. R.T. Penson, S.P. Joel, M. Roberts, A. Gloyne, S. Beckwith, M.L. Slevin The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide Br J Clin Pharmacol 53 2002 347 354
9. J. Persson, J. Hasselstrom, A. Maurset, I. Oye, J.O. Svensson, O. Almqvist Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity Eur J Clin Pharmacol 57 2002 869 875
10. D.J. Belle, J.T. Callaghan, J.C. Gorski, J.F. Maya, O. Mousa, S.A. Wrighton The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity Br J Clin Pharmacol 53 2002 67 74
11. S. Strid, O. Borga, C. Edenius, K.G. Jostell, T. Odergren, A. Weil Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke Eur J Clin Pharmacol 58 2002 409 415
12. J. Lloyd, A. Raven ACRPI handbook of clinical research 2nd ed 1994 Churchill Livingstone Edinburgh (UK) p. 95, 245, 443-53
13. J.I. Gallin Principles and practice of clinical research 1st ed 2002 Academic Press San Diego (CA) p. 75, 127
14. P.A. Buchwalder, T. Buclin, I. Trinchard, A. Munafo, J. Biollaz Pharmacokinetics and pharmacodynamics of IFN-β1a in healthy volunteers J Interferon Cytokine Res 20 2000 857 866
15. C. Robatel, L.A. Decosterd, J. Biollaz, P. Eckert, M.D. Schaller, T. Buclin Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients J Clin Pharmacol 43 2003 1329 1340
16. G. Voortman, J. Van de Post, R.C. Schoemaker, J.M.A. Van Gerven Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon) by Pen-injector and syringe Hum Reprod 14 1999 1698 1702
17. A. Saez, N. Bosh, N. Boadas, A. Arguello, D. Horvat, G. Dinapoli Pharmacokinetics and acute tolerance of a double virus inactivated plasma derived factor VIII concentrate Haemophilia 5 1999 260 265